Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Inovio Pharmaceuticals, Inc. (INO) had Weighted-Average Shares Outstanding (Diluted) of 38.61M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.07M |
|
$-19.69M |
|
-- |
|
$0.07M |
|
$25.12M |
|
$-25.05M |
|
$5.36M |
|
$-19.69M |
|
$-19.69M |
|
$-19.69M |
|
$-19.69M |
|
$-19.69M |
|
$-19.69M |
|
$-25.05M |
|
$-24.31M |
|
38.61M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
38.61M |
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$71.89M |
|
$3.35M |
|
$15.38M |
|
$87.27M |
|
$27.33M |
|
-- |
|
$8.70M |
|
$36.02M |
|
$51.25M |
|
$51.25M |
|
$51.25M |
|
36.67M |
|
| Cash Flow Statement Financials | |
$-26.87M |
|
$-0.05M |
|
$1.03M |
|
$65.81M |
|
$39.92M |
|
$-25.90M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-38336.97% |
|
-38336.97% |
|
-- |
|
-30140.48% |
|
-30140.48% |
|
$-26.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.05 |
|
1804.65 |
|
-38.43% |
|
-38.43% |
|
-22.57% |
|
-38.43% |
|
$1.40 |
|
$-0.70 |
|
$-0.70 |
|